Riskpilot← Back to searchSign inGet full accessSjöstadsapoteket AB
ABBankruptOrg 5591018857Retail sale of pharmaceutical products · NACE 4773Est. 20170 employees
Revenue 2022
SEK 9,3M
-3% vs 2021
EBITDA margin
0.2%
-91% vs 2021
Equity ratio
-35.2%
Financial strength
Net profit 2022
SEK -1M
-488% vs 2021
| Revenue | SEK 9,3M | -3% |
| EBITDA | SEK 17K | -91% |
| Net profit | SEK -1M | -488% |
| Total assets | SEK 1,9M | -29% |
| Equity | SEK -681K | -302% |
| Employees | 0 | — |
Legal name
Sjöstadsapoteket AB
Org number
5591018857
Legal form
Aktiebolag
NACE code
4773 · Retail sale of pharmaceutical products
Founded
22 februari 2017
Share capital
SEK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2022-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget har till föremål för sin verksamhet att bedriva handel med receptbelagda apoteksvaror och handelsvaror som lämpar sig för försäljning och distribution till konsumenter genom apotek samt därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Revenue | 9 630 | 10 255 | 10 029 | 9 622 | 9 292 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −301 | 230 | 138 | 192 | 17 |
| Depreciation & amort. | −272 | −303 | −303 | −303 | −163 |
| EBIT | −573 | −73 | −165 | −111 | −146 |
| Net financials | −36 | −42 | −47 | −62 | −873 |
| Profit before tax | −609 | −115 | −212 | −173 | −1 018 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −609 | −115 | −212 | −173 | −1 018 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Total assets | 2 769 | 2 377 | 2 814 | 2 733 | 1 932 |
| Equity | 124 | 271 | 510 | 337 | −681 |
| Long-term debt | 472 | 158 | 272 | 173 | 275 |
| Short-term debt | 2 173 | 1 947 | 2 033 | 2 223 | 2 338 |
| Total debt | 2 645 | 2 105 | 2 305 | 2 396 | 2 613 |
EBITDA margin
0.2%
This company
15.8%
Market median
-99% vs market
20182022
Equity ratio
-35.2%
This company
38.2%
Market median
-192% vs market
20182022
Return on equity
-101800000.0%
This company
18.4%
Market median
-553260970% vs market
20182022
Net profit margin
-11.0%
This company
8.1%
Market median
-236% vs market
20182022
Asset turnover
4.81×
This company
1.12×
Market median
+329% vs market
20182022
Debt / equity
3.84×
This company
0.62×
Market median
-519% vs market
20182022
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JK Chief Auditor | Chief Auditor | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2020 | |
| Deputy Board Member | 2020 | |
| Former (2) | ||
| Board of Directors | 2020 – 2022 | |
| Chairman | 2020 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 99% | 99% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
C. Frosth Consulting AB
Sjöstadsapoteket AB Board members of Sjöstadsapoteket AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jon Karl Lahiru Nilsson | Chief Auditor | 0 companies |
| Gerda Cathrine Frost | Board of Directors | 0 companies |
| Kerstin Catharina Möller | Board of Directors | 0 companies |
| Clas Ola Hobér | Deputy Board Member | 0 companies |
| Björn Emil Möller | Chairman | 0 companies |